Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: MissionIR

Rhino Resource Partners LP (RHNO) Starts Presentation at SeeThruEquity Conference

Rhino Resource Partners (OTC: RHNO) is a diversified energy limited partnership that is focused on coal and energy related assets and activities, including energy infrastructure investments. The company produces metallurgical and steam coal in a variety of basins throughout the … Continue reading

Posted in SeeThruEquity Conference | Leave a comment

Progressive Care, Inc. (RXMD) Starts Presentation at SeeThruEquity Conference

Progressive Care (OTC: RXMD), through its subsidiary, PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and … Continue reading

Posted in SeeThruEquity Conference | Leave a comment

Cellectar Biosciences, Inc. (CLRB) Starts Presentation at SeeThruEquity Conference

Cellectar Biosciences (NASDAQ: CLRB) is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. These novel small-molecules have demonstrated highly selective uptake and retention … Continue reading

Posted in SeeThruEquity Conference | Leave a comment

PCM, Inc. (PCMI) Starts Presentation at SeeThruEquity Conference

PCM (NASDAQ: PCMI) (formerly known as PC Mall, Inc.) is a technology solutions provider to businesses, government and educational institutions and individual consumers. The company markets its products, services and solutions through a 700+ sales force, field service teams and … Continue reading

Posted in SeeThruEquity Conference | Leave a comment

Calmare Therapeutics Inc. (CTTC) Starts Presentation at SeeThruEquity Conference

Calmare Therapeutics (OTC: CTTC) researches, develops and commercializes chronic, neuropathic pain and wound affliction devices. The company’s flagship medical device – the Calmare® Pain Therapy Device – is the only non-invasive and non-addictive modality that can successfully treat chronic, neuropathic … Continue reading

Posted in SeeThruEquity Conference | Leave a comment

BIO-key International, Inc. (BKYI) Starts Presentation at SeeThruEquity Conference

BIO-key International (OTC: BKYI) provides of fingerprint biometric identification, secure mobile credentialing, and user identity verification solutions to reduce risk and protect the value of their services and assets. BIO-key’s products are software-based and optimized to deliver fast and accurate … Continue reading

Posted in SeeThruEquity Conference | Leave a comment

Staffing 360 Solutions, Inc. (STAF) Starts Presentation at SeeThruEquity Conference

Staffing 360 Solutions (NASDAQ: STAF) is engaged in the acquisition of domestic and international staffing organizations. Through this high growth buy-and-build model, the company has expanded from roughly $5 million in revenues in 2013 to over $145 million in revenues … Continue reading

Posted in SeeThruEquity Conference | Leave a comment

3TL Technologies Corp. (TTMZF) Starts Presentation at SeeThruEquity Conference

3TL Technologies (OTC: TTMZF) is the creator of Platform3, a Software-as-a-Service (SaaS) consumer marketing platform that enables Consumer Packaged Goods (CPG) companies and consumer brands to engage shoppers through their mobile device and influence their purchasing decisions. Platform3 encompasses proprietary … Continue reading

Posted in SeeThruEquity Conference | Leave a comment

RespireRx Pharmaceuticals, Inc. (CORX) Starts Presentation at NobleCon12 Investor Conference

RespireRx Pharmaceuticals, Inc. (OTC: CORX), formerly Cortex Pharmaceuticals, Inc., has multiple drug development programs targeted toward the treatment of brain-related breathing disorders, such as obstructive or central sleep apnea and drug-induced respiratory depression – areas where current treatment options are … Continue reading

Posted in Noble Equity Conference | Leave a comment

OpGen, Inc. (OPGN) Starts Presentation at NobleCon12 Investor Conference

OpGen, Inc. (NASDAQ: OPGN) is developing and deploying precision medicine tools for antibiotic stewardship management in global healthcare settings, adding real benefits to antimicrobial stewardship programs and assisting clinicians with more rapid information about life threatening infections. Using molecular testing … Continue reading

Posted in Noble Equity Conference, Small Cap News | Leave a comment